These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 15824362

  • 1. An open label study of the effects of rituximab in neuromyelitis optica.
    Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C.
    Neurology; 2005 Apr 12; 64(7):1270-2. PubMed ID: 15824362
    [Abstract] [Full Text] [Related]

  • 2. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.
    Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, De Angelis T, Matiello M, Cree BA.
    Arch Neurol; 2008 Nov 12; 65(11):1443-8. PubMed ID: 18779415
    [Abstract] [Full Text] [Related]

  • 3. Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Ikeda K, Araki Y, Iwasaki Y.
    Neurology; 2007 Apr 17; 68(16):1326; author reply 1327. PubMed ID: 17441229
    [No Abstract] [Full Text] [Related]

  • 4. A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica.
    Mangat P, Ravindran J, Cleland L, Limaye V.
    Clin Rheumatol; 2008 Dec 17; 27 Suppl 2():S67-9. PubMed ID: 18560921
    [Abstract] [Full Text] [Related]

  • 5. Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Kister I, Herbert J, Swerdlow ML, Bergamaschi R, Piccolo G, Oger J.
    Neurology; 2007 Apr 17; 68(16):1326-7; author reply 1327. PubMed ID: 17441230
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab.
    Pellkofer HL, Suessmair C, Schulze A, Hohlfeld R, Kuempfel T.
    Mult Scler; 2009 Aug 17; 15(8):1006-8. PubMed ID: 19667025
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosus.
    Nasir S, Kerr DA, Birnbaum J.
    Arch Neurol; 2009 Sep 17; 66(9):1160-3. PubMed ID: 19752308
    [Abstract] [Full Text] [Related]

  • 12. Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders.
    Petereit HF, Rubbert-Roth A.
    Mult Scler; 2009 Feb 17; 15(2):189-92. PubMed ID: 18971221
    [Abstract] [Full Text] [Related]

  • 13. CNS aquaporin-4 autoimmunity in children.
    McKeon A, Lennon VA, Lotze T, Tenenbaum S, Ness JM, Rensel M, Kuntz NL, Fryer JP, Homburger H, Hunter J, Weinshenker BG, Krecke K, Lucchinetti CF, Pittock SJ.
    Neurology; 2008 Jul 08; 71(2):93-100. PubMed ID: 18509092
    [Abstract] [Full Text] [Related]

  • 14. Devic's neuromyelitis optica in an infant case.
    Yuksel D, Senbil N, Yilmaz D, Yavuz Gurer YK.
    J Child Neurol; 2007 Sep 08; 22(9):1143-6. PubMed ID: 17890418
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
    Evangelopoulos ME, Andreadou E, Koutsis G, Koutoulidis V, Anagnostouli M, Katsika P, Evangelopoulos DS, Evdokimidis I, Kilidireas C.
    J Neurol Sci; 2017 Jan 15; 372():92-96. PubMed ID: 28017256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.